<DOC>
	<DOCNO>NCT01786278</DOCNO>
	<brief_summary>The objective study comparison efficacy safety palliative therapy single-dose brachytherapy selfexpanding metal stent ( SEMS ) malignant dysphagia result adenocarcinoma esophago-gastric junction .</brief_summary>
	<brief_title>Comparison Study Brachytherapy Endoscopic Stenting Dysphagia Esophago-Gastric Junction Cancer</brief_title>
	<detailed_description>Over past two decade observe clear trend increase incidence adenocarcinoma esophagus esophago-gastric junction . More half patient already inoperable disease presentation . Most need palliative treatment relieve progressive dysphagia . Presently , endoscopic placement cover selfexpanding metal stent commonly use method treatment malignant dysphagia . Cancer overgrowth stent migration common complication endoscopic stenting occur frequently long time stenting . Specific location esophago-gastric junction end point propulsive force swallow may predispose stent easy migration stomach . Additionally , advance chemotherapy result improved median survival advance adenocarcinoma ot stomach esophago-gastric junction even 10-12 month increase potential high chance occurrence stent complication . Brachytherapy prove valuable durable method treat malignant dysphagia result esophageal mainly squamous cell cancer . For many year irradiation recommend adenocarcinoma esophagus esophago-gastric junction due putative low sensitivity radiotherapy . Recently external beam radiation incorporate combined modality therapy regimens also adenocarcinoma esophagus . Thus , brachytherapy could attractive durable method improve swallow adenocarcinoma esophago-gastric junction , well . Single-dose brachytherapy endoscopic stenting SEMS relieve dysphagia result clearly define adenocarcinoma esophago-gastric junction compare yet .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Adenocarcinoma esophagogastric junction define adenocarcinoma involve low esophagus upper stomach epicenter primary tumor 5cm 5cm anatomic esophagogastric junction Inoperable cancer locally advance irresectible cancer , distant metastasis patient 's condition fit undergo curative therapy Dysphagia score 24 Performance status 60100 Signed inform consent Esophageal squamous cell carcinoma Esophageal adenocarcinoma Gastric cancer Performance status &lt; 60 Instable cardiocirculatory respiratory disorder Concurrent external beam radiation therapy Previous anticancer therapy relate current adenocarcinoma esophagogastric junction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>adenocarcinoma</keyword>
	<keyword>esophago-gastric junction</keyword>
	<keyword>dysphagia</keyword>
	<keyword>brachytherapy</keyword>
	<keyword>endoscopic stenting</keyword>
</DOC>